Indefinite Delivery Contract SPE2DX18D8901
- Not listed
- The federal Indefinite Delivery Contract (IDC) SPE2DB24D8001 was awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $999,999,999.00 single-award contract covers a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support the medical supply chain operations for the U.S. Armed Forces. The contract originates from DLA Troop Support Medical's standing solicitation SPE2DH-21-R-0002 for the ECAT...
- The indefinite delivery contract (IDC) SPE2DX18D8902 was awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, on July 19, 2018. The contract has a ceiling value of $4,999,999.00 and a period of performance through December 31, 2025. Under this IDC, Dakota Drug, Inc. is the prime contractor responsible for providing a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces...
- The federal contract IDV award SPE2DB24D8003 was issued by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The single-award indefinite delivery contract, valued up to $999,999,999.00, covers the period of performance from June 6, 2024 to December 31, 2025. Under this contract, Dakota Drug, Inc. will provide a wide range of pharmaceutical products,...
- The federal contract IDV award SPM20005D0979 is a single-award Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc., a small disadvantaged business. The contract is set aside for total small business and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract's primary purpose is to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The awarded task...
- This Indefinite Delivery Contract (IDC) with award ID SPE2DX18D8903 was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Dakota Drug, Inc. The single-award IDC has a ceiling value of $4,999,999.00 and a period of performance through December 31, 2025. Under this IDC, Dakota Drug, Inc., a small disadvantaged business, is tasked with providing a broad range of pharmaceutical products, medical supplies, and healthcare...
- This Indefinite Delivery Contract (IDC) with a ceiling value of $92,841,709.00 was awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, identified as SPE2DX15D8000, is a single-award IDC set aside for small businesses to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations under the TRICARE North...
- This indefinite delivery contract (IDC) with award number SPE2DB24D8002 was awarded by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract has a ceiling value of $999,999,999.00 and a period of performance through December 31, 2025. It is a single award IDC without any set-aside designations. The contract primarily aims to procure a wide range of pharmaceutical...
- The federal contract IDV award SPE2DX15D3104 is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $999,999,999.00, aims to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including...
- The federal contract IDV award, SPE2DX16D9947, is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This single-award IDC was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, with a ceiling value of $4,999,999.99 and a period of performance through December 25, 2025. Under this IDC, Amerisourcebergen Drug Corp serves as the prime contractor responsible for providing a comprehensive...
- The federal contract IDV award SPE2DX16D2911 is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The single-award IDC, valued at up to $4,999,999.99, was issued by the Defense Logistics Agency (DLA) Troop Support Medical and runs through December 31, 2025. Under this IDC, Amerisourcebergen Drug Corp provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The federal contract IDV award SPE2DX18D8901 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical division to the prime contractor Dakota Drug, Inc. The contract, valued at up to $4,999,999.00, has a period of performance extending through December 31, 2025. Under this IDC, Dakota Drug, Inc., a self-certified small disadvantaged business, is the sole provider of a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract enables the company to efficiently deliver critical medical items such as prescription medications, medical devices, vaccines, and various healthcare-related supplies to various defense healthcare facilities. This award is part of the DLA Troop Support Medical's ECAT Generation V Program, which aims to provide a diverse array of pharmaceutical and medical products, including antibiotics, hormone treatments, pain management medications, diabetes management supplies, respiratory medications, and immunological treatments, to the U.S. military.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 7/19/18 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Pharmaceutical Prime Vendor Global | SPM2DP-13-R-0007 | Defense Logistics Agency Troop Support Medical | Award Notice 1/1 | 8/20/13, 10:37 AM |